Evaluation of (o)-[77Br]bromohippuran as renal tubular function agent.
(o)-[77Br]bromohippuran (BHIP) was developed as renal tubular function agent due to its favourable chemical and physical properties and compared to (o)-[131I]iodohippuran (IHIP). Renograms obtained from baboons were compared and absorbed radiation dose calculations performed. Although BHIP showed a delayed kidney uptake and washout pattern, good kidney clearance of the radionuclide was obtained after 30 min. Radiation dose values for BHIP were markedly lower than for IHIP indicating that larger activities of BHIP could be administered to increase counting statistics. BHIP imaging in normal volunteers did however not substantiate the favourable behaviour obtained in the primate.
D000818:Animals; D001966:Bromine; D005069:Evaluation Studies as Topic; D007839:Functional Laterality; D007465:Iodohippuric Acid / Q000031:analogs & derivatives*; D007668:Kidney / Q000502:physiology; D007677:Kidney Function Tests; D007684:Kidney Tubules / Q000000981:diagnostic imaging*; D010215:Papio; D011868:Radioisotopes; D011877:Radionuclide Imaging; D014018:Tissue Distribution; D001743:Urinary Bladder / Q000000981:diagnostic imaging
D011868:Radioisotopes; D007465:Iodohippuric Acid; C039113:2-bromohippuric acid; D001966:Bromine